Drug Approval | January 21, 2025
Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
Based on ECHO Phase III trial results which showed more than 16 months of progression-free survival improvement vs. chemoimmunotherapy alone
Antibe Therapeutics is a clinical-stage biotechnological company developing novel drugs primarily focusing on reducing pain and inflammation
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Difluprednate Ophthalmic Emulsion, 0.05% is a topical corticosteroid that is indicated in the treatment of inflammation and pain associated with ocular surgery
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Subscribe To Our Newsletter & Stay Updated
